Paying attention to importance to the innovation in retinal surgery_Chinese Journal of Ocular Fundus Diseases

Authors：

 Li Xiaorong , Ren Xinjun

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital. Tianjin 300384, China;

Corresponding author：

Li Xiaorong, Email: xiaorli@163.com

Keywords：

Vitrectomy; Surgical innovation; Retinal diseases; Editorial

DOI：

10.3760/cma.j.cn511434-20231211-00478

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

With the continuous advancement of technology, the field of retinal surgery is poised to witness an increasing array of innovations and breakthroughs. The innovation in retinal surgery plays a pivotal role in enhancing the success rate of operations, reducing the risk of complications, and improving patient prognosis and quality of life. This encompasses innovations in vitrectomy systems, the novel application of vitrectomy in treating other ocular diseases, advancements in retinal surgical techniques, technological and conceptual innovations, as well as multidisciplinary collaboration, all of which contribute to the ongoing development in the treatment of retinal diseases. Therefore, innovations in retinal surgery should receive significant attention from ophthalmologists specializing in retinal diseases with the best service to patients.

Citation： Li Xiaorong, Ren Xinjun. Paying attention to importance to the innovation in retinal surgery. Chinese Journal of Ocular Fundus Diseases, 2023, 39(12): 959-963. doi: 10.3760/cma.j.cn511434-20231211-00478 Copy

1.	Anastasilakis K, Mourgela A, Kaniouras D, et al. Tips, tricks, and advantages of 27-G vitrectomy[J]. Ophthalmologica, 2018, 239(2-3): 176-177. DOI: 10.1159/000485519.
2.	Kunikata H, Aizawa N, Sato R, et al. Successful surgical outcomes after 23-, 25- and 27-gauge vitrectomy without scleral encircling for giant retinal tear[J]. Jpn J Ophthalmol, 2020, 64(5): 506-515. DOI: 10.1007/s10384-020-00755-y.
3.	Pollack JS, Sabherwal N. Small gauge vitrectomy: operative techniques[J]. Curr Opin Ophthalmol, 2019, 30(3): 159-164. DOI: 10.1097/ICU.0000000000000568.
4.	Doi Y, Muraoka Y, Tsujikawa A. Evaluation of the efficiency and safety of a 27-gauge 20000 cuts per minute vitreous cutter[J]. Clin Ophthalmol, 2023, 17: 2037-2043. DOI: 10.2147/OPTH.S418371.
5.	Ahronovich EZ, Simaan N, Joos KM. A review of robotic and OCT-aided systems for vitreoretinal surgery[J]. Adv Ther, 2021, 38(5): 2114-2129. DOI: 10.1007/s12325-021-01692-z.
6.	Salvetat ML, Pellegrini F, Spadea L, et al. Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview[J]. Vision (Basel), 2023, 7(4): 72. DOI: 10.3390/vision7040072.
7.	Wang Y, Xu L, Jonas JB. Frequency of non-arteritic anterior ischaemic optic neuropathy in adult Chinese: the Beijing eye study[J]. Br J Ophthalmol, 2007, 91(3): 401. DOI: 10.1136/bjo.2006.103788.
8.	Kim DH, Shin GR, Choi YJ. Risk factors for non-arteritic anterior ischaemic optic neuropathy in a Korean population[J]. Neuroophthalmology, 2017, 41(2): 68-75. DOI: 10.1080/01658107.2016.1267771.
9.	Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy[J]. Eye (Lond), 2015, 29(1): 65-79. DOI: 10.1038/eye.2014.144.
10.	Hayreh SS. Ischemic optic neuropathy[J]. Prog Retin Eye Res, 2009, 28(1): 34-62. DOI: 10.1016/j.preteyeres.2008.11.002.
11.	Chen J, Zhu J, Chen L, et al. Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: a PRISMA-compliant meta-analysis[J/OL]. Medicine (Baltimore), 2019, 98(46): e17861[2019-11-01]. https://pubmed.ncbi.nlm.nih.gov/31725628/. DOI: 10.1097/MD.0000000000017861.
12.	Fugara NA, Shawareb ZA, Rakkad NK, et al. The risk of non-arteritic ischemic optic neuropathy post-intravitreal Bevacizumab injection[J/OL]. Cureus, 2022, 14(10): e30185[2022-10-11]. https://pubmed.ncbi.nlm.nih.gov/36397890/. DOI: 10.7759/cureus.30185.
13.	Parsa CF, Hoyt WF. Nonarteritic anterior ischemic optic neuropathy (NAION): a misnomer. Rearranging pieces of a puzzle to reveal a nonischemic papillopathy caused by vitreous separation[J]. Ophthalmology, 2015, 122(3): 439-442. DOI: 10.1016/j.ophtha.2014.11.011.
14.	Li D, Sun S, Liang J, et al. Papillary vitreous detachment as a possible accomplice in non-arteritic anterior ischaemic optic neuropathy[J/OL]. Br J Ophthalmol, 2023, 13: bjo-2022-322726[2023-04-13]. https://pubmed.ncbi.nlm.nih.gov/37055157/. DOI: 10.1136/bjo-2022-322726.
15.	Olivera M, Botella J, Lázaro-Rodríguez V, et al. Surgical mobilization of an arterial embolus in cilioretinal artery occlusion[J]. Indian J Ophthalmol, 2022, 70(1): 296-298. DOI: 10.4103/ijo.IJO_791_21.
16.	Liu W, Bai D, Kou L. Progress in central retinal artery occlusion: a narrative review[J/OL]. J Int Med Res, 2023, 51(9): 3000605231198388[2023-09-01]. https://pubmed.ncbi.nlm.nih.gov/37712755/. DOI: 10.1177/03000605231198388.
17.	Ali Said Y, Dewilde E, Stalmans P. Visual outcome after vitrectomy with subretinal tPA injection to treat submacular hemorrhage secondary to age-related macular degeneration or macroaneurysm[J/OL]. J Ophthalmol, 2021, 2021: 3160963[2021-12-30]. https://pubmed.ncbi.nlm.nih.gov/35003789/. DOI: 10.1155/2021/3160963.
18.	Ogata M, Oh H, Nakata A, et al. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator[J/OL]. Sci Rep, 2022, 12(1): 22139[2022-12-22]. https://pubmed.ncbi.nlm.nih.gov/36550175/. DOI: 10.1038/s41598-022-26289-6.
19.	Kumagai K, Ogino N, Fukami M, et al. Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients[J]. Graefe's Arch Clin Exp Ophthalmol, 2020, 258(9): 1893-1899. DOI: 10.1007/s00417-020-04756-y.
20.	Ankamah E, Siemerink MJ, Polkinghorne PJ, et al. Internal drainage of subretinal fluid druging changeller-assisted scleral buckling[J]. Retin Cases Brief Rep, 2022, 16(1): 77-80. DOI: 10.1097/ICB.0000000000000921.
21.	任新军, 郑传珍, 温德佳, 等. 27G玻璃体切割手术联合Healaflow覆盖视网膜裂孔治疗孔源性视网膜脱离的初步研究[J]. 中华眼底病杂志, 2020, 36(3): 200-204. DOI: 10.3760/cma.j.cn511434-20190729-00239.Ren XJ, Zheng CZ, Wen DJ, et al. Patching retinal breaks with Healaflow in 27G vitrectomy in the treatment of rhegmatogenous retinal detachment[J]. Chin J Ocul Fundus Dis, 2020, 36(3): 200-204. DOI: 10.3760/cma.j.cn511434-20190729-00239.
22.	Ren XJ, Bu SC, Wu D, et al. Patching retinal breaks with healaflow in 27-gauge vitrectomy for the treatment of rhematogenous retinal detachment[J]. Retina, 2020, 40(10): 1900-1908. DOI: 10.1097/IAE.0000000000002701.
23.	Ying HF, Wu SQ, Hu WP, et al. Vitrectomy with residual internal limiting membrane covering and autologous blood for a secondary macular hole: a case report[J]. World J Clin Cases, 2022, 10(2): 671-676. DOI: 10.12998/wjcc.v10.i2.671.
24.	Kastl G, Heidenkummer P, Koss MJ. 360° inverted internal limiting membrane flap technique for idiopathic macular holes ≤ 250 µm, > 250 and ≤ 400 µm, and > 400 µm[J]. Graefe's Arch Clin Exp Ophthalmol, 2022, 260(7): 2183-2190. DOI: 10.1007/s00417-022-05587-9.
25.	Felfeli T, Corrin M, Papanikolaou J, et al. Macular hole hydrodissection technique with human amniotic memberane for repair of large macular holes[J]. Retin Cases Brief Rep, 2023, 17(6): 767-770. DOI: 10.1097/ICB.0000000000001293.
26.	Iannetta D, Chhablani J, Valsecchi N, et al. Epiretinal implant of human amniotic membrane to treat highly myopic macular hole retinal detachments: a novel surgical technique[J/OL]. Eur J Ophthalmol, 2023, 11: 11206721231206717[2023-10-11]. https://pubmed.ncbi.nlm.nih.gov/37820366/. DOI: 10.1177/11206721231206717.
27.	郑传珍, 任新军, 柯屹峰, 等. 最小量化玻璃体切除术治疗严重增生性糖尿病视网膜病变的初步观察[J]. 中华眼科杂志, 2021, 57(6): 440-446. DOI: 10.3760/cma.j.cn112142-20200812-00538.Zheng CZ, Ren XJ, Ke YF, et al. Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy[J]. Chin J Ophthalmol, 2021, 57(6): 440-446. DOI: 10.3760/cma.j.cn112142-20200812-00538.

1. Anastasilakis K, Mourgela A, Kaniouras D, et al. Tips, tricks, and advantages of 27-G vitrectomy[J]. Ophthalmologica, 2018, 239(2-3): 176-177. DOI: 10.1159/000485519.
2. Kunikata H, Aizawa N, Sato R, et al. Successful surgical outcomes after 23-, 25- and 27-gauge vitrectomy without scleral encircling for giant retinal tear[J]. Jpn J Ophthalmol, 2020, 64(5): 506-515. DOI: 10.1007/s10384-020-00755-y.
3. Pollack JS, Sabherwal N. Small gauge vitrectomy: operative techniques[J]. Curr Opin Ophthalmol, 2019, 30(3): 159-164. DOI: 10.1097/ICU.0000000000000568.
4. Doi Y, Muraoka Y, Tsujikawa A. Evaluation of the efficiency and safety of a 27-gauge 20000 cuts per minute vitreous cutter[J]. Clin Ophthalmol, 2023, 17: 2037-2043. DOI: 10.2147/OPTH.S418371.
5. Ahronovich EZ, Simaan N, Joos KM. A review of robotic and OCT-aided systems for vitreoretinal surgery[J]. Adv Ther, 2021, 38(5): 2114-2129. DOI: 10.1007/s12325-021-01692-z.
6. Salvetat ML, Pellegrini F, Spadea L, et al. Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview[J]. Vision (Basel), 2023, 7(4): 72. DOI: 10.3390/vision7040072.
7. Wang Y, Xu L, Jonas JB. Frequency of non-arteritic anterior ischaemic optic neuropathy in adult Chinese: the Beijing eye study[J]. Br J Ophthalmol, 2007, 91(3): 401. DOI: 10.1136/bjo.2006.103788.
8. Kim DH, Shin GR, Choi YJ. Risk factors for non-arteritic anterior ischaemic optic neuropathy in a Korean population[J]. Neuroophthalmology, 2017, 41(2): 68-75. DOI: 10.1080/01658107.2016.1267771.
9. Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy[J]. Eye (Lond), 2015, 29(1): 65-79. DOI: 10.1038/eye.2014.144.
10. Hayreh SS. Ischemic optic neuropathy[J]. Prog Retin Eye Res, 2009, 28(1): 34-62. DOI: 10.1016/j.preteyeres.2008.11.002.
11. Chen J, Zhu J, Chen L, et al. Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: a PRISMA-compliant meta-analysis[J/OL]. Medicine (Baltimore), 2019, 98(46): e17861[2019-11-01]. https://pubmed.ncbi.nlm.nih.gov/31725628/. DOI: 10.1097/MD.0000000000017861.
12. Fugara NA, Shawareb ZA, Rakkad NK, et al. The risk of non-arteritic ischemic optic neuropathy post-intravitreal Bevacizumab injection[J/OL]. Cureus, 2022, 14(10): e30185[2022-10-11]. https://pubmed.ncbi.nlm.nih.gov/36397890/. DOI: 10.7759/cureus.30185.
13. Parsa CF, Hoyt WF. Nonarteritic anterior ischemic optic neuropathy (NAION): a misnomer. Rearranging pieces of a puzzle to reveal a nonischemic papillopathy caused by vitreous separation[J]. Ophthalmology, 2015, 122(3): 439-442. DOI: 10.1016/j.ophtha.2014.11.011.
14. Li D, Sun S, Liang J, et al. Papillary vitreous detachment as a possible accomplice in non-arteritic anterior ischaemic optic neuropathy[J/OL]. Br J Ophthalmol, 2023, 13: bjo-2022-322726[2023-04-13]. https://pubmed.ncbi.nlm.nih.gov/37055157/. DOI: 10.1136/bjo-2022-322726.
15. Olivera M, Botella J, Lázaro-Rodríguez V, et al. Surgical mobilization of an arterial embolus in cilioretinal artery occlusion[J]. Indian J Ophthalmol, 2022, 70(1): 296-298. DOI: 10.4103/ijo.IJO_791_21.
16. Liu W, Bai D, Kou L. Progress in central retinal artery occlusion: a narrative review[J/OL]. J Int Med Res, 2023, 51(9): 3000605231198388[2023-09-01]. https://pubmed.ncbi.nlm.nih.gov/37712755/. DOI: 10.1177/03000605231198388.
17. Ali Said Y, Dewilde E, Stalmans P. Visual outcome after vitrectomy with subretinal tPA injection to treat submacular hemorrhage secondary to age-related macular degeneration or macroaneurysm[J/OL]. J Ophthalmol, 2021, 2021: 3160963[2021-12-30]. https://pubmed.ncbi.nlm.nih.gov/35003789/. DOI: 10.1155/2021/3160963.
18. Ogata M, Oh H, Nakata A, et al. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator[J/OL]. Sci Rep, 2022, 12(1): 22139[2022-12-22]. https://pubmed.ncbi.nlm.nih.gov/36550175/. DOI: 10.1038/s41598-022-26289-6.
19. Kumagai K, Ogino N, Fukami M, et al. Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients[J]. Graefe's Arch Clin Exp Ophthalmol, 2020, 258(9): 1893-1899. DOI: 10.1007/s00417-020-04756-y.
20. Ankamah E, Siemerink MJ, Polkinghorne PJ, et al. Internal drainage of subretinal fluid druging changeller-assisted scleral buckling[J]. Retin Cases Brief Rep, 2022, 16(1): 77-80. DOI: 10.1097/ICB.0000000000000921.
21. 任新军, 郑传珍, 温德佳, 等. 27G玻璃体切割手术联合Healaflow覆盖视网膜裂孔治疗孔源性视网膜脱离的初步研究[J]. 中华眼底病杂志, 2020, 36(3): 200-204. DOI: 10.3760/cma.j.cn511434-20190729-00239.Ren XJ, Zheng CZ, Wen DJ, et al. Patching retinal breaks with Healaflow in 27G vitrectomy in the treatment of rhegmatogenous retinal detachment[J]. Chin J Ocul Fundus Dis, 2020, 36(3): 200-204. DOI: 10.3760/cma.j.cn511434-20190729-00239.
22. Ren XJ, Bu SC, Wu D, et al. Patching retinal breaks with healaflow in 27-gauge vitrectomy for the treatment of rhematogenous retinal detachment[J]. Retina, 2020, 40(10): 1900-1908. DOI: 10.1097/IAE.0000000000002701.
23. Ying HF, Wu SQ, Hu WP, et al. Vitrectomy with residual internal limiting membrane covering and autologous blood for a secondary macular hole: a case report[J]. World J Clin Cases, 2022, 10(2): 671-676. DOI: 10.12998/wjcc.v10.i2.671.
24. Kastl G, Heidenkummer P, Koss MJ. 360° inverted internal limiting membrane flap technique for idiopathic macular holes ≤ 250 µm, > 250 and ≤ 400 µm, and > 400 µm[J]. Graefe's Arch Clin Exp Ophthalmol, 2022, 260(7): 2183-2190. DOI: 10.1007/s00417-022-05587-9.
25. Felfeli T, Corrin M, Papanikolaou J, et al. Macular hole hydrodissection technique with human amniotic memberane for repair of large macular holes[J]. Retin Cases Brief Rep, 2023, 17(6): 767-770. DOI: 10.1097/ICB.0000000000001293.
26. Iannetta D, Chhablani J, Valsecchi N, et al. Epiretinal implant of human amniotic membrane to treat highly myopic macular hole retinal detachments: a novel surgical technique[J/OL]. Eur J Ophthalmol, 2023, 11: 11206721231206717[2023-10-11]. https://pubmed.ncbi.nlm.nih.gov/37820366/. DOI: 10.1177/11206721231206717.
27. 郑传珍, 任新军, 柯屹峰, 等. 最小量化玻璃体切除术治疗严重增生性糖尿病视网膜病变的初步观察[J]. 中华眼科杂志, 2021, 57(6): 440-446. DOI: 10.3760/cma.j.cn112142-20200812-00538.Zheng CZ, Ren XJ, Ke YF, et al. Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy[J]. Chin J Ophthalmol, 2021, 57(6): 440-446. DOI: 10.3760/cma.j.cn112142-20200812-00538.

Chinese Journal of Ocular Fundus Diseases

Paying attention to importance to the innovation in retinal surgery

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content